O se faʻatagaga faʻatagaina mo se togafitiga faʻasolosolo o faʻamaʻi sickle cell e tatau ona faia ia Mati,
Crispr Fofo
fai mai, faʻamaonia le taʻimua a le kamupani i se vaega faʻatauvaʻa o suʻesuʻega faafomaʻi ma faʻaosoina se tupe maua i le faʻasoa.
Afai e fa'amaonia, o le exa-cel treatment mai ia Crispr (ticker: CRSP) ma lana paaga
Vertex Faletalavai
(VRTX) o le a avea muamua ma togafitiga US-maketi fa'avae ile Crispr—a Tekinolosi manumalo Nobel lea e toe tusia ai kenera sese. O ma'i na maua le togafitiga e tasi i fa'ata'ita'iga falema'i ua tumau pea le sa'olotoga le faaletonu o le toto mumuauga tiga.
Punavai: https://www.barrons.com/articles/crispr-therapeutics-stock-fda-sickle-cell-gene-therapy-bf56a18c?siteid=yhoof2&yptr=yahoo